610 related articles for article (PubMed ID: 29056067)
1. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.
Narita M; Imai S; Nakamura A; Ozeki A; Asato M; Rahmadi M; Sudo Y; Hojo M; Uezono Y; Devi LA; Kuzumaki N; Suzuki T
Addict Biol; 2013 Jul; 18(4):614-22. PubMed ID: 21812868
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
4. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
[TBL] [Abstract][Full Text] [Related]
5. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.
DeWire SM; Yamashita DS; Rominger DH; Liu G; Cowan CL; Graczyk TM; Chen XT; Pitis PM; Gotchev D; Yuan C; Koblish M; Lark MW; Violin JD
J Pharmacol Exp Ther; 2013 Mar; 344(3):708-17. PubMed ID: 23300227
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
[TBL] [Abstract][Full Text] [Related]
8. Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine.
Mori T; Takemura Y; Arima T; Iwase Y; Narita M; Miyano K; Hamada Y; Suda Y; Matsuzawa A; Sugita K; Matsumura S; Sasaki S; Yamauchi T; Higashiyama K; Uezono Y; Yamazaki M; Kuzumaki N; Narita M
Biochem Biophys Res Commun; 2021 Jan; 534():988-994. PubMed ID: 33139013
[TBL] [Abstract][Full Text] [Related]
9. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
Bohn LM; Gainetdinov RR; Lin FT; Lefkowitz RJ; Caron MG
Nature; 2000 Dec; 408(6813):720-3. PubMed ID: 11130073
[TBL] [Abstract][Full Text] [Related]
10. Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula.
Komatsu A; Miyano K; Nakayama D; Mizobuchi Y; Uezono E; Ohshima K; Karasawa Y; Kuroda Y; Nonaka M; Yamaguchi K; Iseki M; Uezono Y; Hayashida M
Anesth Analg; 2022 May; 134(5):1082-1093. PubMed ID: 35427270
[TBL] [Abstract][Full Text] [Related]
11. Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor.
Ramos-Gonzalez N; Groom S; Sutcliffe KJ; Bancroft S; Bailey CP; Sessions RB; Henderson G; Kelly E
Br J Pharmacol; 2023 Sep; 180(18):2341-2360. PubMed ID: 37005796
[TBL] [Abstract][Full Text] [Related]
12. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
[TBL] [Abstract][Full Text] [Related]
14. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
[TBL] [Abstract][Full Text] [Related]
15. Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine.
Mizobuchi Y; Miyano K; Manabe S; Uezono E; Komatsu A; Kuroda Y; Nonaka M; Matsuoka Y; Sato T; Uezono Y; Morimatsu H
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327617
[TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
[TBL] [Abstract][Full Text] [Related]
17. Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses.
Manabe S; Miyano K; Fujii Y; Ohshima K; Yoshida Y; Nonaka M; Uzu M; Matsuoka Y; Sato T; Uezono Y; Morimatsu H
J Pharmacol Sci; 2019 Jun; 140(2):171-177. PubMed ID: 31320243
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of fentanyl mediated β-arrestin biased signaling.
de Waal PW; Shi J; You E; Wang X; Melcher K; Jiang Y; Xu HE; Dickson BM
PLoS Comput Biol; 2020 Apr; 16(4):e1007394. PubMed ID: 32275713
[TBL] [Abstract][Full Text] [Related]
19. Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist.
Doi S; Mori T; Uzawa N; Arima T; Takahashi T; Uchida M; Yawata A; Narita M; Uezono Y; Suzuki T; Narita M
Mol Pain; 2016; 12():. PubMed ID: 27317580
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents.
Altarifi AA; David B; Muchhala KH; Blough BE; Akbarali H; Negus SS
J Psychopharmacol; 2017 Jun; 31(6):730-739. PubMed ID: 28142305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]